Society for Immunotherapy of Cancer (SITC)
Eleanor Rickman is a seasoned professional with a strong background in program management and communication within environmental and health organizations. Currently serving as Program Manager at the Society for Immunotherapy of Cancer since May 2021, Eleanor previously held the role of Program Coordinator at the same organization. Prior experience includes a Communications Intern position at the Urban Ecology Center and a Development Fellow role at the Wisconsin League of Conservation Voters. Additional experience encompasses service learning partnerships at the Midwest Renewable Energy Association and Groundwork Milwaukee, internships at Feeding America Eastern Wisconsin and Noodles & Company, as well as a developmental focus on service and communication through various roles. Eleanor holds a Bachelor of Arts degree in English Rhetoric and Professional Writing from the University of Wisconsin-Milwaukee, completed in 2021, and graduated from Rhinelander High School in 2017.
This person is not in the org chart
Society for Immunotherapy of Cancer (SITC)
The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. sitc_log_color.png Established in 1984, SITC, a 501(c)(3) not-for-profit organization, serves scientists, clinicians, academicians, patients, patient advocates, government representatives and industry leaders from around the world. Through educational programs that foster scientific exchange and collaboration, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Currently, SITC has more than 2,000 members who represent 22 medical specialties in 42 countries around the world. Through emphasis on high-caliber scientific meetings; dedication to education and outreach activities; focus on initiatives of major importance in the field; and commitment to collaborations with like-minded domestic and international organizations, government and regulatory agencies, associations and patient advocacy groups, SITC brings together all aspects of the cancer immunology and immunotherapy community. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.